Amphastar Pharmaceuticals : Quarterly Report for Quarter Ending 2022-06-30 (Form 10-Q)
Table of Contents ​ UNITED STATES SECURITIES AND EXCHANGE COMMISSION ... | August 9, 2022
Source: marketscreener.com
📰 Interactive Data File News
Page 13 - Interactive Data File News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Interactive Data File. Real-time updates on events, politics, business and more.
SunPower : Quarterly Report for Quarter Ending July 3, 2022 (Form 10-Q)
Operating and finance leases 3.3 3.5 3.3 3.5 ... | August 3, 2022
United States Dorado Devco Sunpower Financial Hannon Armstrong Revenue Service Hemlock Semiconductor Corporation
Source: marketscreener.com
Richardson Electronics : Annual Report for Fiscal Year Ending --05-28, 2022 (Form 10-K)
Rell-10k_20220528.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ...
Source: marketscreener.com
Investegate |3M Company Announcements | 3M Company: Half-year Report
Investegate announcements from 3M Company, Half-year Report
United States Asia Pacific Food Safety Division Electronics Health Careconsumer Total Company Health Care Business Group Solutions Division
Source: investegate.co.uk
Kiniksa Pharmaceuticals : 2021 Annual Report
Every Second Counts! ANNUAL 20 REPORT 21 Dear Fellow Shareholders, ... | June 27, 2022
United States Sanjk Patel Smaller Reporting Company Growth Company Drug Administration Commission File Number
Source: marketscreener.com
Tyme Technologies : Annual Report (Form 10-K)
Tyme-10k_20220331.htm Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ... | May 25, 2022
Source: marketscreener.com
BiondVax Pharmaceuticals : Annual Report by Foreign Issuer (Form 20-F)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ... | March 28, 2022
United States Israel General Hadassah Ein Kerem Amir Reichman Biondvax Pharmaceuticals Ltd Israel Companies Law
Source: marketscreener.com
2021 Annual Report – InsuranceNewsNet
2021 marked a year of transition for Essent. For the year, we earned $682 million or $6.11 per diluted share, compared to net income of $413 million or $3.88 per diluted share in 2020, while generating a 17% retuon average equity. The U.S. housing market has been a bright spot in the current economic cycle, exhibiting resilience and strength.
Source: insurancenewsnet.com
Artelo Biosciences : Annual Transition Report (Form 10-KT)
Artl_10kt.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION ... | March 21, 2022
Source: marketscreener.com
Zogenix : Amendment to Annual Report (Form 10-K/A)
10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM ... | March 7, 2022
Source: marketscreener.com